Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > Doing the math
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by longonMJon Jan 26, 2018 11:19pm
192 Views
Post# 27445793

RE:RE:RE:RE:RE:RE:RE:RE:RE:Doing the math

RE:RE:RE:RE:RE:RE:RE:RE:RE:Doing the mathWell, by putting a cap on the number of dollars that they are willing to pay out for this takeover, it would appear clear to me that Aurora would much rather pay with issuing more shares, as opposed to paying with cash.

As a result, Aurora would much rather have their share price stay above the implied price of $12.65 per share as this would entice Cannimed shareholders to take the 3.4X all share exchange since they would be ahead by taking this option.  If the Aurora shares were trading under the $12.65 implied price, the Cannimed shareholders would then opt for the part share and part cash offer since they would be ahead with this option instead.


VENMan wrote: There is two options in this deal for CMED Shareholders (1) You get 3.4 shares of ACB for every share of CMED you have. (2) You get $5.70 Cash per every share of CMED you have and 2.9 shares of ACB for every CMED share you have. You have to contact your Self Direct Broker and tell them what option you want. ACB has put a cap of $140 million for those CMED shareholders that want cash and 2.9 ACB shares. ALL IMO !! GLTA !  


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities